JK Rockstroh

2.7k total citations
63 papers, 1.9k citations indexed

About

JK Rockstroh is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, JK Rockstroh has authored 63 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Epidemiology, 31 papers in Hepatology and 26 papers in Infectious Diseases. Recurrent topics in JK Rockstroh's work include Hepatitis C virus research (31 papers), HIV/AIDS drug development and treatment (21 papers) and Liver Disease Diagnosis and Treatment (17 papers). JK Rockstroh is often cited by papers focused on Hepatitis C virus research (31 papers), HIV/AIDS drug development and treatment (21 papers) and Liver Disease Diagnosis and Treatment (17 papers). JK Rockstroh collaborates with scholars based in Germany, United Kingdom and Spain. JK Rockstroh's co-authors include Lennart Hammarström, Pascal Schneider, A D Webster, H. H. Peter, Bodo Grimbacher, Helen Chapel, Alejandro A. Schäffer, Michael Schlesier, Ulrich Salzer and Qiang Pan‐Hammarström and has published in prestigious journals such as Nature Genetics, Clinical Infectious Diseases and Journal of Hepatology.

In The Last Decade

JK Rockstroh

59 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
JK Rockstroh Germany 19 782 775 489 420 417 63 1.9k
P. B. A. Kernoff United Kingdom 23 477 0.6× 506 0.7× 211 0.4× 427 1.0× 239 0.6× 75 2.3k
Sorin Rugină Romania 11 441 0.6× 249 0.3× 210 0.4× 259 0.6× 117 0.3× 65 1.6k
Joaquin Valdes United States 16 1.1k 1.4× 453 0.6× 968 2.0× 887 2.1× 357 0.9× 31 2.6k
Soo Aleman Sweden 21 357 0.5× 1.2k 1.5× 323 0.7× 177 0.4× 1.0k 2.5× 121 1.9k
Matthew Cramp United Kingdom 25 384 0.5× 1.5k 2.0× 1.1k 2.2× 150 0.4× 1.9k 4.6× 79 3.1k
Janez Tomažič Slovenia 15 542 0.7× 323 0.4× 229 0.5× 334 0.8× 76 0.2× 51 1.7k
Juergen Rockstroh Germany 26 712 0.9× 1.2k 1.5× 264 0.5× 486 1.2× 1.2k 2.8× 47 2.0k
Giorgio Barbarini Italy 31 762 1.0× 1.4k 1.7× 102 0.2× 427 1.0× 963 2.3× 88 2.5k
Lise Cuzin France 27 1.1k 1.4× 688 0.9× 200 0.4× 770 1.8× 119 0.3× 101 1.8k
Eoin R. Feeney Ireland 15 421 0.5× 486 0.6× 113 0.2× 290 0.7× 346 0.8× 53 1.1k

Countries citing papers authored by JK Rockstroh

Since Specialization
Citations

This map shows the geographic impact of JK Rockstroh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JK Rockstroh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JK Rockstroh more than expected).

Fields of papers citing papers by JK Rockstroh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by JK Rockstroh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JK Rockstroh. The network helps show where JK Rockstroh may publish in the future.

Co-authorship network of co-authors of JK Rockstroh

This figure shows the co-authorship network connecting the top 25 collaborators of JK Rockstroh. A scholar is included among the top collaborators of JK Rockstroh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with JK Rockstroh. JK Rockstroh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grint, Daniel, Lars Peters, Joanne Reekie, et al.. (2013). Stability of hepatitis C virus (HCV) RNA levels among interferon‐naïve HIV/HCV‐coinfected individuals treated with combination antiretroviral therapy. HIV Medicine. 14(6). 370–378. 15 indexed citations
2.
Neukam, Karin, Jacob Nattermann, Norma Rallón, et al.. (2011). Different distributions of hepatitis C virus genotypes among HIV-infected patients with acute and chronic hepatitis C according to interleukin-28B genotype. HIV Medicine. 12(8). 487–493. 12 indexed citations
3.
Lutz, Philipp, JC Wasmuth, Hans Dieter Nischalke, et al.. (2011). Progression of liver fibrosis in HIV/HCV genotype 1 co-infected patients is related to the T allele of the rsI2979860 polymorphism of the IL28B gene. European journal of medical research. 16(8). 335–335. 8 indexed citations
4.
Vogel, M., Emma Page, Christoph Boesecke, et al.. (2011). Liver Fibrosis Progression After Acute Hepatitis C Virus Infection in HIV-Positive Individuals. Clinical Infectious Diseases. 54(4). 556–559. 26 indexed citations
5.
Rodríguez‐Torres, M., Francesca J. Torriani, JK Rockstroh, et al.. (2010). Degree of Viral Decline Early in Treatment Predicts Sustained Virological Response in HCV-HIV Coinfected Patients Treated with Peginterferon Alfa-2a and Ribavirin. HIV Clinical Trials. 11(1). 1–10. 5 indexed citations
6.
Anadol, Evrim, Rolf Kaiser, Jens Verheyen, et al.. (2010). Transmission of Human Immunodeficiency Virus I Drug Resistance - a Case Report. What are the Clinical Implications?. European journal of medical research. 15(5). 225–225. 1 indexed citations
7.
Vogel, M., Golo Ahlenstiel, Thomas A. Lutz, et al.. (2010). The influence of HAART on the efficacy and safety of pegylated interferon and ribavirin therapy for the treatment of chronic HCV infection in HIV-positive individuals. European journal of medical research. 15(3). 102–11. 8 indexed citations
8.
Antinori, Andrea, T Coenen, Nikos Dedes, et al.. (2010). Late presentation of HIV infection: a consensus definition. HIV Medicine. 12(1). 61–64. 353 indexed citations
9.
Reuter, Stefan, Dawn Meyer, Heribert Knechten, et al.. (2009). Präexpositionsprophylaxe bei HIV – Vision oder bald Realität?. DMW - Deutsche Medizinische Wochenschrift. 134(50). 2582–2584. 2 indexed citations
10.
Ewig, Santiago, et al.. (2008). Kardiale Manifestationen bei fortgeschrittener HIV-Infektion. DMW - Deutsche Medizinische Wochenschrift. 119(19). 683–689. 2 indexed citations
11.
Sagir, Abdurrahman, Mark Oette, Rolf Kaiser, et al.. (2007). Trends of prevalence of primary HIV drug resistance in Germany. Journal of Antimicrobial Chemotherapy. 60(4). 843–848. 44 indexed citations
12.
Wasmuth, JC, Isabel Lambertz, Esther Voigt, et al.. (2007). Maintenance of indinavir by dose adjustment in HIV-1-infected patients with indinavir-related toxicity. European Journal of Clinical Pharmacology. 63(10). 901–908. 7 indexed citations
13.
Salzer, Ulrich, Qiang Pan‐Hammarström, Annette Schmitt‐Graeff, et al.. (2005). Mutations in TACI are associated with immunodeficient phenotypes in humans.. Clinical Immunology. 115(2). 129–30. 3 indexed citations
14.
Salzer, Ulrich, Helen Chapel, A D Webster, et al.. (2005). Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nature Genetics. 37(8). 820–828. 476 indexed citations
15.
Mauss, S, Stefan Scholten, Eva Wolf, et al.. (2004). A prospective, controlled study assessing the effect of lopinavir on amprenavir concentrations boosted by ritonavir. HIV Medicine. 5(1). 15–17. 8 indexed citations
16.
Rockstroh, JK & Ulrich Spengler. (2004). HIV-infection: modern antiretroviral therapy. DMW - Deutsche Medizinische Wochenschrift. 129(37). 1921–1924. 1 indexed citations
17.
Winkler, Petra, Sabine Ellinger, Bianca M. Arendt, et al.. (2004). Lymphocyte proliferation and apoptosis in HIV-seropositive and healthy subjects during long-term ingestion of fruit juices or a fruit-vegetable-concentrate rich in polyphenols and antioxidant vitamins. European Journal of Clinical Nutrition. 58(2). 317–325. 15 indexed citations
18.
19.
Bierhoff, E., Hans‐Peter Fischer, JK Rockstroh, et al.. (1997). Liver histopathology in patients with concurrent chronic hepatitis C and HIV infection. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 430(4). 271–277. 59 indexed citations
20.
Ewig, Santiago, et al.. (1996). Effect of long-term primary aerosolized pentamidine prophylaxis on breakthrough Pneumocystis carinii pneumonia. European Respiratory Journal. 9(5). 1006–1012. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P. B. A. Kernoff Breakdown of academic impact, for papers by Sorin Rugină Breakdown of academic impact, for papers by Joaquin Valdes Breakdown of academic impact, for papers by Soo Aleman Breakdown of academic impact, for papers by Matthew Cramp Breakdown of academic impact, for papers by Janez Tomažič Breakdown of academic impact, for papers by Juergen Rockstroh Breakdown of academic impact, for papers by Giorgio Barbarini Breakdown of academic impact, for papers by Lise Cuzin Breakdown of academic impact, for papers by Eoin R. Feeney
Rankless by CCL
2026